$670 Million is the total value of SABBY MANAGEMENT, LLC's 132 reported holdings in Q3 2020. The portfolio turnover from Q2 2020 to Q3 2020 was 60.7% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| Sell | BIOGEN INCput | $66,920,000 | -1.7% | 2,359 | -7.3% | 9.99% | -26.9% | |
| Sell | SPDR SERIES TRUSTput | $14,898,000 | -42.5% | 1,337 | -42.2% | 2.22% | -57.2% | |
| BIIB | Sell | BIOGEN INC | $12,634,000 | -54.6% | 44,536 | -57.1% | 1.89% | -66.2% |
| Sell | ISHARES NASDAQ BIOTECHput | $12,498,000 | -13.2% | 923 | -12.3% | 1.87% | -35.4% | |
| Sell | SORRENTO THERAPEUTICSput | $7,964,000 | +25.8% | 7,143 | -29.1% | 1.19% | -6.5% | |
| Sell | BRAINSTORM CELL THERAPEUTICSput | $7,519,000 | -77.3% | 4,444 | -52.4% | 1.12% | -83.2% | |
| Sell | PLURISTEM THERAPEUTICSput | $6,301,000 | +16.1% | 5,984 | -2.5% | 0.94% | -13.6% | |
| Sell | AVEO PHARMACEUTICALS INCput | $4,040,000 | +7.4% | 6,801 | -6.9% | 0.60% | -20.1% | |
| Sell | TRILLIUM THERAPEUTICS INCcall | $2,643,000 | +43.6% | 1,860 | -18.2% | 0.40% | +7.0% | |
| CRIS | Sell | CURIS INC | $1,380,000 | -49.7% | 1,179,600 | -48.0% | 0.21% | -62.6% |
| FGEN | Sell | FIBROGEN INC | $1,219,000 | -10.4% | 29,654 | -11.6% | 0.18% | -33.3% |
| NRBO | Sell | NEUROBO PHARMACEUTICALS | $1,026,000 | -45.2% | 182,543 | -21.5% | 0.15% | -59.3% |
| Sell | ALTIMMUNE INCput | $1,005,000 | -67.2% | 761 | -73.4% | 0.15% | -75.6% | |
| Sell | ODONATE THERAPEUTICS INCput | $475,000 | -76.4% | 354 | -25.5% | 0.07% | -82.4% | |
| XLV | Sell | SELECT SECTOR SPDR TRetf | $422,000 | -96.0% | 4,000 | -96.2% | 0.06% | -97.0% |
| PAVMZ | Sell | PAVMED INC*w | $364,000 | -58.0% | 436,973 | -48.1% | 0.05% | -69.0% |
| SCPH | Sell | SCPHARMACEUTICALS INC | $316,000 | -65.9% | 42,407 | -66.3% | 0.05% | -74.7% |
| Sell | GENOCEA BIOSCIENCES INCcall | $236,000 | -51.7% | 1,032 | -51.5% | 0.04% | -64.3% | |
| AUPH | Sell | AURINIA PHARMACEUTICALS | $200,000 | -50.7% | 13,544 | -45.8% | 0.03% | -63.0% |
| AVEO | Sell | AVEO PHARMACEUTICALS INC | $155,000 | -65.6% | 26,039 | -70.2% | 0.02% | -74.4% |
| Sell | BAUDAX BIO INCput | $114,000 | -40.0% | 410 | -10.7% | 0.02% | -55.3% | |
| MDGSW | Sell | MEDIGUS LTD*w | $93,000 | -24.4% | 544,940 | -7.0% | 0.01% | -44.0% |
| RWLK | Exit | REWALK ROBOTICS LTD | $0 | – | -19,082 | -100.0% | -0.01% | – |
| TEUM | Exit | PARETEUM CORP | $0 | – | -56,757 | -100.0% | -0.01% | – |
| Exit | CELSION CORPput | $0 | – | -145 | -100.0% | -0.01% | – | |
| ENLV | Exit | ENLIVEX THERAPEUTICS LTD | $0 | – | -12,925 | -100.0% | -0.01% | – |
| MARK | Exit | REMARK HOLDINGS INC | $0 | – | -33,953 | -100.0% | -0.02% | – |
| Exit | REMARK HOLDINGS INCput | $0 | – | -413 | -100.0% | -0.02% | – | |
| HOTH | Exit | HOTH THERAPEUTICS INC | $0 | – | -68,681 | -100.0% | -0.04% | – |
| Exit | ALTIMMUNE INCcall | $0 | – | -189 | -100.0% | -0.04% | – | |
| BPTH | Exit | BIO PATH HLDGS INC | $0 | – | -45,000 | -100.0% | -0.05% | – |
| XBI | Exit | SPDR SERIES TRUSTetf | $0 | – | -2,150 | -100.0% | -0.05% | – |
| Exit | CELSION CORPcall | $0 | – | -653 | -100.0% | -0.05% | – | |
| AIKI | Exit | AIKIDO PHARMA INC | $0 | – | -342,121 | -100.0% | -0.06% | – |
| Exit | ORAMED PHARMS INCput | $0 | – | -949 | -100.0% | -0.07% | – | |
| ATNM | Exit | ACTINIUM PHARMACEUTICALS | $0 | – | -972,285 | -100.0% | -0.07% | – |
| Exit | PREDICTIVE ONCOLOGY INC | $0 | – | -223,540 | -100.0% | -0.07% | – | |
| GNPX | Exit | GENPREX INC | $0 | – | -118,584 | -100.0% | -0.08% | – |
| Exit | TRILLIUM THERAPEUTICSput | $0 | – | -527 | -100.0% | -0.09% | – | |
| YTRA | Exit | YATRA ONLINE INC | $0 | – | -650,000 | -100.0% | -0.09% | – |
| IMUX | Exit | IMMUNIC INC | $0 | – | -53,009 | -100.0% | -0.13% | – |
| AVGR | Exit | AVINGER INC | $0 | – | -2,183,464 | -100.0% | -0.14% | – |
| MBIO | Exit | MUSTANG BIO INC | $0 | – | -234,778 | -100.0% | -0.15% | – |
| SOLY | Exit | SOLITON INC | $0 | – | -102,891 | -100.0% | -0.16% | – |
| Exit | ODONATE THERAPEUTICS INCcall | $0 | – | -223 | -100.0% | -0.19% | – | |
| CLDX | Exit | CELLDEX THERAPEUTICS INC | $0 | – | -73,094 | -100.0% | -0.19% | – |
| NKLAW | Exit | NIKOLA CORP*w | $0 | – | -34,500 | -100.0% | -0.23% | – |
| GLBS | Exit | GLOBUS MARITIME LTD | $0 | – | -4,776,735 | -100.0% | -0.26% | – |
| Exit | AVEO PHARMACEUTICALS INCcall | $0 | – | -4,255 | -100.0% | -0.44% | – | |
| Exit | NIKOLA CORPput | $0 | – | -345 | -100.0% | -0.47% | – | |
| ALNA | Exit | ALLENA PHARMACEUTICALS | $0 | – | -1,531,446 | -100.0% | -0.49% | – |
| PLL | Exit | PIEDMONT LITHIUM LTD | $0 | – | -498,259 | -100.0% | -0.58% | – |
| XERS | Exit | XERIS PHARMACEUTICALS | $0 | – | -1,086,031 | -100.0% | -0.58% | – |
| Exit | SORRENTO THERAPEUTICS INCcall | $0 | – | -5,155 | -100.0% | -0.65% | – | |
| Exit | SPDR GOLD TRUSTput | $0 | – | -215 | -100.0% | -0.72% | – | |
| Exit | INOVIO PHARMACEUTICALScall | $0 | – | -2,494 | -100.0% | -1.35% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-11-16
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| SPDR S&P 500 ETF TRUST UNIT | 37 | Q3 2023 | 49.1% |
| ISHARES TR | 35 | Q3 2023 | 52.2% |
| SPDR S&P BIOTECHNOLOGY | 32 | Q3 2022 | 12.8% |
| AMARIN CORP PLC | 30 | Q4 2021 | 2.0% |
| BIOGEN INC | 24 | Q1 2021 | 26.2% |
| SAREPTA THERAPEUTICS INC | 24 | Q3 2020 | 4.6% |
| BIOGEN INC | 23 | Q1 2021 | 13.7% |
| SAREPTA THERAPEUTICS INC | 22 | Q3 2020 | 6.2% |
| BRAINSTORM CELL THERAPEUTICS INC | 21 | Q3 2023 | 1.6% |
| VERTEX PHARMACEUTICALS INC | 20 | Q1 2018 | 12.6% |
View SABBY MANAGEMENT, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| AGM GROUP HOLDINGS, INC. | January 10, 2023 | 627,936 | 2.6% |
| Bit Digital, Inc | January 10, 2023 | 3,166,917 | 3.8% |
| Cingulate Inc. | January 10, 2023 | 10 | 5.0% |
| Context Therapeutics Inc. | January 10, 2023 | 796,706 | 5.0% |
| HeartBeam, Inc. | January 10, 2023 | 271,788 | 3.4% |
| PharmaCyte Biotech, Inc. | January 10, 2023 | 934,456 | 5.0% |
| Rebus Holdings, Inc.Sold out | January 10, 2023 | 0 | 0.0% |
| TANTECH HOLDINGS LTD | January 10, 2023 | 41,500 | 0.6% |
| Quanergy Systems, Inc. | January 04, 2023 | 936,905 | 5.8% |
| TuanChe Ltd | January 04, 2023 | 2,384,713 | 10.0% |
View SABBY MANAGEMENT, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| SC 13G | 2024-01-04 |
| SC 13G | 2024-01-04 |
| SC 13G | 2024-01-04 |
| SC 13G | 2024-01-04 |
| SC 13G | 2024-01-04 |
| SC 13G | 2024-01-03 |
| SC 13G | 2024-01-03 |
| SC 13G | 2024-01-03 |
| SC 13G | 2024-01-03 |
View SABBY MANAGEMENT, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.